1. Home
  2. Detail

@i4j.x: #شعر #قصيد #CapCut #اكسبلور #تصاميم_فيديوهات🎵🎤🎬

﮼الشنب٦٠٤ 𒆜.
﮼الشنب٦٠٤ 𒆜.
Open In TikTok:
Region: AE
Wednesday 12 August 2026 18:05:20 GMT
16531
774
6
101

Music

Download

No Watermark .mp4 (0.36MB) No Watermark(HD) .mp4 (0.52MB) Watermark .mp4 (0.72MB) Music .mp3

Comments

ie539_10
﴿الشاعر ابو محمد عـامِـر🦅﴾ :
اي والله
2026-08-22 19:38:56
0
user9300665842904
حازم العدله :
انشهد
2026-09-01 07:06:38
0
user7391247390334
العيون الساهرة :
🥰🥰🥰
2026-08-23 18:05:45
0
user33322463506287
ابو زيد البارق :
🥰🥰🥰
2026-08-21 16:34:00
0
user3257563513079
محمد علي علي المعاف :
✌️✌️✌️
2026-08-17 10:46:13
0
dy6idaja1lbx
نايف مقحيل✌️😎🫡✔️ :
😎✌️✌️✌️
2026-08-26 07:48:23
0
To see more videos from user @i4j.x, please go to the Tikwm homepage.

Other Videos

Kha da chi wrana shuwla khabara 😌🤫❤️#fyppppppppppppppppppppppp #viralvideo
Kha da chi wrana shuwla khabara 😌🤫❤️#fyppppppppppppppppppppppp #viralvideo
⚪️👉🏻Ya no es necesario realizar cortes para extraer piedras formadas en el riñón, vejiga, uretra. Así es la Unidad de Piso Pélvico de Spacio Médico de Ventura Mall. @Spacio.Medico #Salud #Bolivia #Pelvis #spaciomedico #explainer
⚪️👉🏻Ya no es necesario realizar cortes para extraer piedras formadas en el riñón, vejiga, uretra. Así es la Unidad de Piso Pélvico de Spacio Médico de Ventura Mall. @Spacio.Medico #Salud #Bolivia #Pelvis #spaciomedico #explainer
Le Mali🇲🇱..... un peuple porté par le courage, une nation qui avance avec fierté, un nom qui résonne au coeur de l'Afrique, L'Édit de SOLOTO pour le 22 septembre, bonne fête du 22 septembre à tous les maliens #capcut #soloto #fyp #edit
Le Mali🇲🇱..... un peuple porté par le courage, une nation qui avance avec fierté, un nom qui résonne au coeur de l'Afrique, L'Édit de SOLOTO pour le 22 septembre, bonne fête du 22 septembre à tous les maliens #capcut #soloto #fyp #edit
Membalas @orgil utamakan borongan bolo minat langsung DM / WAWA DI bio #fangfengfong #sopotelpon #fangfengfongtullslup #setiaplukapunyacerita
Membalas @orgil utamakan borongan bolo minat langsung DM / WAWA DI bio #fangfengfong #sopotelpon #fangfengfongtullslup #setiaplukapunyacerita
Proses memang tak mudah, tapi result dia? MEMANG KEBABOOM! 💥🔥 Nak tengok banyal lagi? Jom beli tiket dan saksaiksna CHELOT di pawagam hari ini! #CHELOT
Proses memang tak mudah, tapi result dia? MEMANG KEBABOOM! 💥🔥 Nak tengok banyal lagi? Jom beli tiket dan saksaiksna CHELOT di pawagam hari ini! #CHELOT
🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming
🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming

About

Legal